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In the 45 years that I have spent in hospital practice 
and academic medicine in Malta and abroad, I have 
-

marvelled at the explosion of medical knowledge and 
the changes of medical practice that have taken place 
throughout the years. One could truly say that there 
were more advances in medicine in the last 60 years 
than there had been in the previous 500 years. Indeed 
the medical breakthroughs of the last 50 years have 
probably saved more lives than those of any epoch since 
medicine began. 
In the 1930s, the Civilian General Hospital was the 
Central Hospital in Floriana. St Luke's was planned in 
1927 when the population of Malta was 230,000; the 
foundation stone was laid in April 1930 and it was 
planned to have 450 beds. The work was interrupted 
during the World War Two and by the time it was fully 
commissioned in 1950, the bed status was increased to 
536 beds. Even at the time it did not solve the problem 
of accommodation. If one reads the report of the Chief 
Government Medical Officer for the year 1951, he men­
tioned the problems of overcrowding even at a time 
when the number of patients admitted during that year 
was 2,917 and the total number of attendances at the 
outpatient department was 14,952. These figures are a 
far cry from those of 1999 when there were 43,518 in­
patients and 181 ,818 outpatient attendances! 
In the 1930s and 1940s, the major threats to life in 
Malta were tuberculosis, tetanus, pneumonia, meningi­
tis, polio, brucellosis, typhoid, septicaemia and rheu­
matic fever. The only anti-infective agent available at 
the time was the sulphonamide Prontosil discovered by 
Domagk in 1935. At that time, the digitalis glycosides 
were used in heart disease and the major life-saving 
therapeutic agent was insulin, which was introduced in 
1923 by Banting and Best for the treatment of Diabetes 
Mellitus. Penicillin, discovered by Fleming and first 
tried in mice in 1940, was used for the first time on 
Maltese patients by the late Professor P P De Bono in 
1942 after he had obtained a small supply from the Brit­
ish Army Hospital at Mtarfa (Paul Cassar, personal 
communication). This heralded the introduction of 
other antibiotics, of which, in 1999 there were over 100. 
By 1955, Tetracycline and Chloromycetin were added 
to Pencillin and Sulphonamides, which were already 
available. Streptomycin and other anti tuberculosis 
drugs such as PAS and INAH were also introduced. 
The major infections in Malta (brucellosis, typhoid, 
diphtheria, typhus and pulmonary tuberculosis) were 
being brought under control. The Poliomyelitis vaccine 
became available in Malta in 1955. Since that time, 
progress in the therapeutics of infectious diseases have 
resulted in the elimination of many of these diseases. 
Smallpox has been eradicated and poliomyelitis nearly 
wiped out. Vaccines have also helped to control mea­
sles, rubella, tetanus, diphtheria, influenza and other 
infectious diseases. However, since the 1980s, we have 
seen the emergence of new infections such as AIDS and 
also the re-emergence of an old one, tuberculosis. One 
must not forget that improved sanitation and social stan­
dards/status were major factors in bringing infectious 
diseases and infant mortality under control. One can 
safely say that in the last 50 years, the so-called age of 
infections has given way to the age of chronic diseases. 
The diseases affecting the community today are diseases 
of multiple aetiology and long duration. 
During the latter half of the last century, there has 
been a veritable pharmacological revolution. In the 
mid-fifties, one of the first major advances was the in­
troduction of the first group of oral diuretic agents - the 
thiazides. This was then followed by the introduction of 
other major drugs such as the beta-blockers, oral hypo­
glycaemic agents, calcium reflux blockers and ACE In­
hibitors. A major break-through was the use of corti­
sone in 1950 at the Mayo Clinic by Kendal and Hench 
for Rheumatoid Arthritis. The availability of steroids 
made it feasible to capitalise on the growing understand­
ing of the immune system and the availability of im­
muno-suppressants opened the possibility for transplant 
surgery; indeed the first heart transplant was carried out 
in 1967 by Chris Barnard. The pharmacological revolu­
tion, however, affected a much wider field. It produced 
psychotropic drugs like Chlorpromazine, which was the 
first effective medication for mental illness. 
Ware now in the era of designer drugs. Scientists are 
using tools to design drugs from scratch and the key to 
this development was the recognition and isolation of 
cell receptors. Receptor-based drug design focuses on 
the synthesis of ligands that have the specific ability to 
bind to a particular type of cell receptor, which is re­
sponsible for the drug ' s therapeutic effect. Sumatrip­
tan, a drug for migraine, stimulates a receptor that leads 
to the constriction of the dilated vessels responsible for 
the migraine attack. Similarly, the new class of anti­
asthmatic drugs - the anti-leukotrienes - block the spe­
cific receptor that produces bronchospasm. Moreover, 
there is now a new class of drugs consisting of human 
protein manufactured through genetic engineering. Ex­
amples of such drugs are hormones that are identical to 
the ones produced by the body; erythropoietin, which is 
used for the treatment of anaemia of chronic renal fail­
ure, was the first human hormone produced in this fash­
ion. 
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The major changes in medicine in medical practice in the 20th century 
Following the discovery of X-rays at the turn of the 
century, the dramatic increase in the pace of medical 
discovery in 1950s and the early seventies witnessed the 
introduction of non-invasive techniques such as Endo­
scopic procedures, Laparoscopic techniques, Ultra­
sound, Computed Tomography and Magnetic Reso­
nance Imaging. The medical benefits of these new non­
invasive measures had a major impact on clinical prac­
tice. Indeed with laparoscopic surgery, patients experi­
enced substantially less post-operative pain and required 
far shorter hospitalisation and recovery period. One 
should add that the marked advances in anaesthesia 
have contributed to these successful outcomes. 
One of the most dramatic advances was the use of the 
artificial kidney for the treatment of renal failure by 
Scribner in the early 1960s. This technology, highly 
effective, was the first really very expensive treatment 
and as such the forerunner of the introduction of other 
highly priced technologies such as Intensive Therapy 
Unit, Coronary Care Unit, coronary bypass graft surgery 
and angioplasties for ischaemic heart disease, hip and 
knee replacements for osteo-arthritis, vitreo-retinal sur­
gery and ultrasound machines that use shock waves to 
break up kidney stones. Moreover transplantation of the 
kidney, liver, heart, lungs, pancreas and bone marrow 
have made it possible to treat previously hopeless dis­
eases. 
The highly visible progress in clinical medicine had 
put in the shadow another scientific revolution that was 
taking place at the same time. It started with the discov­
ery in the early 1950s by Francis Crick and James Wat­
son that the DNA molecule was configured as the dou­
ble helix. In the 1940s, the DNA molecule was already 
recognised as the vehicle, which carried the crucial ge­
netic information. In the Human Genome Project, it is 
intended to identify all the genes in the nucleus of a hu­
man cell. This scientific collaborative study is planned 
to be finalised by the year 2005. As of the mid-1997, 
2,700 genes of known function have been cloned. The 
genes associated with hereditary diseases such as Cystic 
Fibrosis, Duchenne Muscular Dystrophy and Hunting­
ton's disease have been identified as well as those of 
some cancers and inherited forms of Alzheimer's dis­
ease. Within the next 10 to 20 years, molecular biology 
will be exploiting the critical role that genes play in hu­
man health and disease. Gene science will become an 
inseparable component of health care. Screening pro­
grammes utilising DNA technology together with pre­
emptive treatment targeting vulnerable groups are a re­
alistic probability. New technologies for locating and 
identifying human genes will provide opportunities for 
diagnosis at the level of the genotype with the expecta­
tion that more specifically directed treatment regimes 
and preventive actions may be employed. Perhaps these 
can be used in tackling the challenge of ageing. 
These activities will greatly change the practice of 
medicine. The practice and technology associated with 
gene science will have wide ranging financial, social 
and ethical implications and these have to be resolved 
before one can make any progress. 
In the next 10 to 20 years, the era of bio-engineering 
will reach great heights in areas like miniaturised instru­
mentation, novel uses of biological material and labora­
tory production of human tissue using cell culture tech­
niques. There will also be progress towards artificial 
intelligence components to assist in clinical decision 
making. Molecular medicine will begin to fulfil its po­
tential especially in areas of diagnosis and screening. 
Imaging with fast CT and fast MRI will make it possible 
to detect coronary artery disease in the early stages. 
Fast MRls will also be used to detect lung cancers too 
small to be detected by current techniques; indeed it is 
estimated that lung cancer growth takes two years be­
fore it is detected by a chest X-ray. Positron Emission 
Tomography (PET), which in most places is still a re­
search tool, may afford an early and accurate diagnosis 
of many illnesses such as cancer and mental disease. 
Conventional laboratories may face competition from 
laboratories built on a single computer chip, which will 
permit its use at the patient's home or a doctor's clinic. 
Use of the internet has already resulted in an increas­
ingly demanding and knowledgeable patient. One can 
also envisage a situation where the power of the com­
puter and the universality of the internet connections 
will make tele-medicine on a global scale a reality. The 
growing practice of tele-medicine puts this technology 
to work by allowing physicians to consult on treatment 
of patients even hundreds of miles away. Computers 
that make use of artificial intelligence may potentially 
be useful tools for analysing difficult medical problems 
and advising physicians on the patient's diagnosis. 
However, I strongly hold the view that the computers 
will not be able to replace the physician well-trained in 
medical problem solving. Such skills will continue to 
be vital as even the best designed programmes for clini­
cal problem solving will not be able to weigh all the hu­
man, social, psychological and environmental factors. 
The integration of all the information with the decision 
making process can only be carried out after a good his­
tory is obtained by a competent and humane physician. 
As an eminent Harvard physician so well stated, 'The 
secret of care of the patient, is caring for the patient. ' 
It is a credit to the Maltese medical profession that it 
has been able to keep abreast of the medical progress 
that has been taking place. I strongly believe that this 
would not have been possible if Malta did not have its 
own University and Medical School. 
The era of modern medicine is full of promise and ex­
citement. However, it is vital that the invasion of the 
patient's privacy should not be allowed to take place 
under the guise of progress. This danger to privacy 
does exist and we must therefore tackle the ethical and 
social issues that accompany medical progress. We 
must never lose sight of the fact that we should be the 
guardians of our patients' best interests. 
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